DE60204982D1 - Mandelatsalze von substituierten tetrazyklischen tetrahydrofuranderivaten - Google Patents

Mandelatsalze von substituierten tetrazyklischen tetrahydrofuranderivaten

Info

Publication number
DE60204982D1
DE60204982D1 DE60204982T DE60204982T DE60204982D1 DE 60204982 D1 DE60204982 D1 DE 60204982D1 DE 60204982 T DE60204982 T DE 60204982T DE 60204982 T DE60204982 T DE 60204982T DE 60204982 D1 DE60204982 D1 DE 60204982D1
Authority
DE
Germany
Prior art keywords
cyclic
substituted tetra
mandelate salts
tetrahydrofurane
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60204982T
Other languages
English (en)
Other versions
DE60204982T2 (de
Inventor
Bart P A M J Medaer
Sigrid C M Stokbroekx
Yves G Ruysschaert
Joannes J M Willems
Johan E E Weerts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Publication of DE60204982D1 publication Critical patent/DE60204982D1/de
Application granted granted Critical
Publication of DE60204982T2 publication Critical patent/DE60204982T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
DE60204982T 2001-11-09 2002-11-08 Mandelatsalze von substituierten tetrazyklischen tetrahydrofuranderivaten Expired - Lifetime DE60204982T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP01204465 2001-11-09
EP01204465 2001-11-09
PCT/EP2002/011136 WO2003040122A1 (en) 2001-11-09 2002-11-08 Novel mandelate salts of substituted tetracyclic tetrahydrofuran derivatives

Publications (2)

Publication Number Publication Date
DE60204982D1 true DE60204982D1 (de) 2005-08-11
DE60204982T2 DE60204982T2 (de) 2006-04-27

Family

ID=8181272

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60204982T Expired - Lifetime DE60204982T2 (de) 2001-11-09 2002-11-08 Mandelatsalze von substituierten tetrazyklischen tetrahydrofuranderivaten

Country Status (25)

Country Link
US (1) US7317115B2 (de)
EP (1) EP1446397B1 (de)
JP (1) JP2005508988A (de)
KR (1) KR100962325B1 (de)
CN (1) CN1582282B (de)
AR (1) AR037285A1 (de)
AT (1) ATE299138T1 (de)
AU (1) AU2002349327B2 (de)
BR (1) BR0212770A (de)
CA (1) CA2465043C (de)
DE (1) DE60204982T2 (de)
EA (1) EA006980B1 (de)
ES (1) ES2244818T3 (de)
HR (1) HRP20040395A2 (de)
HU (1) HUP0402224A3 (de)
IL (2) IL161866A0 (de)
MX (1) MXPA04004365A (de)
MY (1) MY128237A (de)
NO (1) NO328548B1 (de)
NZ (1) NZ531739A (de)
PL (1) PL368456A1 (de)
TW (1) TW200407117A (de)
UA (1) UA79248C2 (de)
WO (1) WO2003040122A1 (de)
ZA (1) ZA200403454B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20050044329A (ko) * 2001-12-07 2005-05-12 얀센 파마슈티카 엔.브이. 트랜스-융합된3,3ａ,8,12ｂ-테트라히드로-2Ｈ-디벤조[3,4:6,7]시클로헵타[1,2-ｂ]푸란 유도체의 제조
WO2005013969A1 (en) * 2003-07-15 2005-02-17 Janssen Pharmaceutica N.V. Antipsychotic agent with socializing properties
RU2401257C2 (ru) 2004-12-07 2010-10-10 Янссен Фармацевтика Н.В. Новые замещенные тетрациклические производные тетрагидрофурана, пирролидина и тетрагидротиофена
EA013595B1 (ru) 2005-01-27 2010-06-30 Янссен Фармацевтика Н.В. Гетероциклические, тетрациклические производные гидрофурана в качестве ингибиторов 5htв терапии расстройств цнс
KR101299518B1 (ko) 2005-06-17 2013-08-29 얀센 파마슈티카 엔.브이. 사이클릭 아민 측쇄를 함유한 신규한 테트라사이클릭테트라하이드로푸란 유도체
US8765223B2 (en) * 2008-05-08 2014-07-01 Air Products And Chemicals, Inc. Binary and ternary metal chalcogenide materials and method of making and using same
US8507040B2 (en) 2008-05-08 2013-08-13 Air Products And Chemicals, Inc. Binary and ternary metal chalcogenide materials and method of making and using same
US8962675B1 (en) * 2013-09-12 2015-02-24 Abbvie Inc. Atrasentan mandelate salts

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3644462A1 (de) * 1986-12-24 1988-07-07 Basf Ag Verfahren zur herstellung von 5h-dibenzo(a,d)cyclohepten-5-onen
JP2656720B2 (ja) * 1992-12-09 1997-09-24 武田薬品工業株式会社 光学活性アミノクマラン誘導体
AU1945495A (en) * 1994-03-16 1995-10-03 Novo Nordisk A/S Acid addition salts of 2,3,4,5-tetrahydro-1h-3-benzazepine compounds
US6057441A (en) 1996-04-12 2000-05-02 Janssen Pharmaceutica, N.V. Substituted tetracyclic tetrahydrofuran derivatives
DK0904060T3 (da) 1996-05-20 2004-04-13 Janssen Pharmaceutica Nv Antifungale præparater med forbedret biotilgængelighed
UA52778C2 (uk) * 1997-10-10 2003-01-15 Янссен Фармацевтика Н.В. Галогенозаміщені тетрациклічні похідні тетрагідрофурану, спосіб їх отримання та композиція на їх основі
US6281247B1 (en) * 1998-03-03 2001-08-28 Novo Nordisk A/S Salt forms of (2E)-5-amino-5-methylhex-2-enoic acid N-methyl-N-((1R)-1-(N-methyl-N-((1R)-1-(methylcarbamoyl)-2-phenylethyl)carbamoyl)-2-(2-naphthyl)ethyl)amide
HUP9904624A2 (hu) * 1999-12-17 2002-01-28 Sanofi-Synthelabo Szacharinszármazékok, eljárás előállításukra, az ezeket tartalmazó gyógyszerkészítmények és intermedierjeik
EP1186303A3 (de) * 2000-09-06 2003-12-10 Pfizer Products Inc. Ein Neutrophilhemmender Faktor und ein selektive NMDA-NR2B Rezeptor Antagonisten enthaltende Kombinationspräparate zur Behandlung von Schlaganfällen und traumatischen Gehirnschäden

Also Published As

Publication number Publication date
CA2465043A1 (en) 2003-05-15
JP2005508988A (ja) 2005-04-07
KR100962325B1 (ko) 2010-06-11
CN1582282A (zh) 2005-02-16
EP1446397B1 (de) 2005-07-06
WO2003040122A1 (en) 2003-05-15
CN1582282B (zh) 2012-06-06
AR037285A1 (es) 2004-11-03
EP1446397A1 (de) 2004-08-18
US7317115B2 (en) 2008-01-08
BR0212770A (pt) 2004-10-13
TW200407117A (en) 2004-05-16
HRP20040395A2 (en) 2005-04-30
IL161866A0 (en) 2005-11-20
EA006980B1 (ru) 2006-06-30
MY128237A (en) 2007-01-31
KR20050044310A (ko) 2005-05-12
ZA200403454B (en) 2005-08-31
US20050085533A1 (en) 2005-04-21
UA79248C2 (en) 2007-06-11
HUP0402224A2 (hu) 2005-02-28
NO20041848L (no) 2004-05-05
CA2465043C (en) 2011-02-15
AU2002349327B2 (en) 2008-10-23
HUP0402224A3 (en) 2007-05-29
MXPA04004365A (es) 2004-08-11
ES2244818T3 (es) 2005-12-16
NO328548B1 (no) 2010-03-15
DE60204982T2 (de) 2006-04-27
IL161866A (en) 2010-04-29
NZ531739A (en) 2005-02-25
ATE299138T1 (de) 2005-07-15
PL368456A1 (en) 2005-03-21
EA200400656A1 (ru) 2004-10-28

Similar Documents

Publication Publication Date Title
DK1360169T3 (da) Succinatsalt af O-desmethyl-venlafaxin
DE60004317D1 (de) Salze von Sulfonium-Verbindungen
AR028596A1 (es) Nuevos derivados de fenilglicina
DK1438306T3 (da) Derivater af UK-2A
DE60236226D1 (de) Verbesserung der Altersweitsichtigkeit
ATE319451T1 (de) Tetrahydrochinolin-derivate
ATE361281T1 (de) Substituierte phenylderivate
ATE312827T1 (de) 3-substituierte-4-pyrimidonderivate
EE200100647A (et) Ühendite uus kasutamine antibakteriaalsete ainetena
DK1412328T3 (da) Dolastatin-10-derivater
CY2009001I2 (el) Νεα μορφη κρυσταλλου του παραγωγου πυρρολιδυλοθειοκαρβαπενεμης
DK1261585T3 (da) Substituerede indol-Mannichbaser
ATE391502T1 (de) Kristalline formen von fluvastatin-natrium
DE60107074D1 (de) Kristallin form ii von cabergolin
DE60224221D1 (de) Aminotetralinderivate, antagonisten von muscarinrezeptoren
DE60204982D1 (de) Mandelatsalze von substituierten tetrazyklischen tetrahydrofuranderivaten
DE60223031D1 (de) Arylpiperazin gebundene tetrahydroindolonderivate
ATE309994T1 (de) Alkoxycarbonylaminobenzoesäure- oder alkoxycarbonylaminotetrazolylphenylderivate als ip-antagonisten
PT1322592E (pt) Derivados substituidos de 1-aminobutan-3-ol
DE60132511D1 (de) E-isomeren von fullerenderivate
ATE342890T1 (de) Polymorph v von torasemid
NO20035248D0 (no) Nye fenylalkyloksy-fenyl derivater
EE200100381A (et) Morfolinobensamiidi uued soolad
ATE256662T1 (de) Amorphe modifikation von torasemid
PT1178984E (pt) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinilamimometilcromano

Legal Events

Date Code Title Description
8364 No opposition during term of opposition